Exchange: NYSE·Updated 05:46 PM EDT

CRL News

News
all
press releases
Here's How Much You Would Have Made Owning Charles River Stock In The Last 20 Years
Charles River (NYSE:CRL) has outperformed the market over the past 20 years by 1.14% on an annualized basis producing an average annual return of 10.15%. Currently, Charles River has a market capitalization of $15.44read more...
Benzinga
Here's How Much You Would Have Made Owning Charles River Stock In The Last 20 Years
Charles River (NYSE:CRL) has outperformed the market over the past 20 years by 1.14% on an annualized basis producing an average annual return of 10.15%. Currently, Charles River has a market capitalization of $15.44read more...
Benzinga
More News
Charles River Collaborates with Magellan Stem Cells to Advance Stem Cell and Regenerative Medicine Development
Charles River Laboratories International, Inc. (NYSE: CRL) and Magellan Stem Cells, a private Australian biotech and cell-therapy firm, announce their collaboration to support Magellan in the development and clinical advancement of its proprietary stem cell-based therapies and regenerative medicine...
Business Wire
Charles River Laboratories Schedules Third-Quarter 2026 Earnings Release and Conference Call
Charles River Laboratories International, Inc. (NYSE: CRL) will release third-quarter 2026 financial results on Wednesday, November 4th, before the market opens. A conference call has been scheduled to discuss this information on Wednesday, November 4th, at 9:00 a.m. ET. Investors will have the...
Business Wire
PGNY or CRL: Which Is the Better Value Stock Right Now?
PGNY vs. CRL: Which Stock Is the Better Value Option?
Zacks
Charles River Gains 75.8% in a Year: What's Driving the Rally?
CRL shares have surged 75.8% in a year as RMS trends improve, AI-enabled testing expands and cash flow supports buybacks and investment.
Zacks
Is It Prudent to Add Teleflex Stock to Your Portfolio Now?
TFX's Vascular growth, Asia expansion and improved leverage support the outlook, but tariffs, input costs and margin pressure remain key risks.
Zacks
Charles River and Autolomous Partner to Transform Laboratory Execution Systems
Charles River Laboratories International, Inc. (NYSE: CRL) and Autolomous today announced the launch of Apollo Orchestrate, a new capability within Charles River's Apollo platform that connects and digitizes laboratory execution, built on Autolomous's autoloMATE digital Laboratory Execution System...
Business Wire
Charles River Laboratories International Now #430 Largest Company, Surpassing Tyler Technologies
In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Charles River Laboratories International Inc. (Symbol: CRL) has taken over the #430 spot from Tyler Technologies, Inc. (Symbol: TYL), according to The Online Investor...
Nasdaq News: Markets
Here's How Much $1000 Invested In Charles River 15 Years Ago Would Be Worth Today
Charles River (NYSE:CRL) has outperformed the market over the past 15 years by 3.32% on an annualized basis producing an average annual return of 16.72%. Currently, Charles River has a market capitalization of $15.15read more...
Benzinga
Is Aveanna Healthcare (AVAH) Stock Outpacing Its Medical Peers This Year?
Here is how Aveanna Healthcare (AVAH) and Charles River Laboratories (CRL) have performed compared to their sector so far this year.
Zacks

Advertisement|Remove ads.